115 related articles for article (PubMed ID: 38218360)
1. FKBP38 suppresses endometrial cancer cell proliferation and metastasis by inhibiting the mTOR pathway.
Yan Y; Wang S; Zhang Z; Tang M; Zhao AZ; Li Z; Wu X; Li F
Arch Biochem Biophys; 2024 Feb; 752():109891. PubMed ID: 38218360
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
[TBL] [Abstract][Full Text] [Related]
3. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR.
Peng L; Liang D; Tong W; Li J; Yuan Z
J Biol Chem; 2010 Jul; 285(27):20870-81. PubMed ID: 20439463
[TBL] [Abstract][Full Text] [Related]
5. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidic acid activates mammalian target of rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an allosteric effect.
Yoon MS; Sun Y; Arauz E; Jiang Y; Chen J
J Biol Chem; 2011 Aug; 286(34):29568-74. PubMed ID: 21737445
[TBL] [Abstract][Full Text] [Related]
7. Silencing FKBP38 gene by siRNA induces activation of mTOR signaling in goat fetal fibroblasts.
Fu YT; Zheng X; He Q; Jia XY; Guo ZX; Yao RY; Wang YF; Wang ZG
Genet Mol Res; 2015 Aug; 14(3):9675-82. PubMed ID: 26345900
[TBL] [Abstract][Full Text] [Related]
8. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
9. Tripartite motif containing 28 (TRIM28) promotes the growth and migration of endometrial carcinoma cells by regulating the AKT/mTOR signaling pathway.
Chen Y; Cheng H; Long H
Gen Physiol Biophys; 2021 May; 40(3):245-252. PubMed ID: 34100380
[TBL] [Abstract][Full Text] [Related]
10. Heat Shock Protein B7 Inhibits the Progression of Endometrial Carcinoma by Inhibiting PI3K/AKT/mTOR Pathway.
Xing M; Wu B; Wang S
Reprod Sci; 2023 Feb; 30(2):590-600. PubMed ID: 35859224
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
12. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
13. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition.
Dunlop EA; Dodd KM; Seymour LA; Tee AR
Cell Signal; 2009 Jul; 21(7):1073-84. PubMed ID: 19272448
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
Wang X; Fonseca BD; Tang H; Liu R; Elia A; Clemens MJ; Bommer UA; Proud CG
J Biol Chem; 2008 Nov; 283(45):30482-92. PubMed ID: 18676370
[TBL] [Abstract][Full Text] [Related]
16. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
Zhang S; Wang M; Li Q; Zhu P
Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
[TBL] [Abstract][Full Text] [Related]
17. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
[No Abstract] [Full Text] [Related]
18. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
Cao C; Zhou JY; Xie SW; Guo XJ; Li GT; Gong YJ; Yang WJ; Li Z; Zhong RH; Shao HH; Zhu Y
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284427
[TBL] [Abstract][Full Text] [Related]
19. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.
Bai X; Ma D; Liu A; Shen X; Wang QJ; Liu Y; Jiang Y
Science; 2007 Nov; 318(5852):977-80. PubMed ID: 17991864
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer Cells.
Tsubamoto H; Inoue K; Sakata K; Ueda T; Takeyama R; Shibahara H; Sonoda T
Anticancer Res; 2017 Feb; 37(2):515-519. PubMed ID: 28179296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
